In contrast, fetuses with SMA type 1 with at least two copies of SMN2 (classic Werdnig–Hoffman) generally do not have phenotypic findings at birth and may escape antenatal detection. This evidence concerns the gene SMN2 and spinal muscular atrophy, type 1.